does tirzepatide cause rapid heart rate Effects of on Ambulatory Blood Pressure and What are the side effects

A landmark 2023 cardiovascular outcomes trial demonstrated that semaglutide reduced major adverse cardiac events by 20%, sparking questions about whether this GLP-1 receptor agonist actively lowers cholesterol or simply works through other mechanisms

I also like to remind clients of the importance of eating enough on GLP-1s

Medication interactions can produce apparent tolerance loss

Whilst diet soda does not interfere with Mounjaro's mechanism of action, focusing on hydrating beverages that contribute to overall nutritional goals may be more beneficial for optimising treatment outcomes and supporting long-term metabolic health